Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Phillips

Showing results (811-820 of 1,132) with videos related to

Pageof 114
Sort By:
The Lancet. Global Health|March 26, 2021
The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysisAndrew N Phillips, Loveleen Bansi-Matharu, Valentina Cambiano, et al.
Proteins|August 28, 2020
The crystal structure of AbsH3: A putative flavin adenine dinucleotide-dependent reductase in the abyssomicin biosynthesis pathwayJonathan A Clinger, Xiachang Wang, Wenlong Cai, et al.
The Journal of Infectious Diseases|April 4, 2002
Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) studyAlessandro Cozzi-Lepri, Andrew N Phillips, Antonella d'Arminio Monforte, et al.
Lancet (London, England)|April 28, 1999
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study GroupG J Weverling, A Mocroft, B Ledergerber, et al.
HIV Medicine|December 13, 2017
Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversionO T Stirrup, A J Copas, A N Phillips, et al.
Antiviral Therapy|May 15, 2002
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA studyA Mocroft, A N Phillips, N Friis-Møller, et al.
Archives of Internal Medicine|April 24, 1995
Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with acquired immunodeficiency syndrome. Multicentre Study Group on AIDS in EuropeJ D Lundgren, S E Barton, C Katlama, et al.
Proteins|March 28, 2009
Structures of two Arabidopsis thaliana major latex proteins represent novel helix-grip foldsBetsy L Lytle, Jikui Song, Norberto B de la Cruz, et al.
Antiviral Therapy|May 14, 2003
Changes in viral load in people with virological failure who remain on the same HAART regimenAlessandro Cozzi-Lepri, Andrew N Phillips, Veronica Miller, et al.
Neurocase|September 22, 2007
Effect of propranolol on naming in chronic Broca's aphasia with anomiaDavid Q Beversdorf, Umesh K Sharma, Nicole N Phillips, et al.
Pageof 114

Showing results (811-820 of 1,132) with videos related to

Sort By:
Pageof 114
The Lancet. Global Health|March 26, 2021
The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysisAndrew N Phillips, Loveleen Bansi-Matharu, Valentina Cambiano, et al.
Proteins|August 28, 2020
The crystal structure of AbsH3: A putative flavin adenine dinucleotide-dependent reductase in the abyssomicin biosynthesis pathwayJonathan A Clinger, Xiachang Wang, Wenlong Cai, et al.
The Journal of Infectious Diseases|April 4, 2002
Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) studyAlessandro Cozzi-Lepri, Andrew N Phillips, Antonella d'Arminio Monforte, et al.
Lancet (London, England)|April 28, 1999
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study GroupG J Weverling, A Mocroft, B Ledergerber, et al.
HIV Medicine|December 13, 2017
Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversionO T Stirrup, A J Copas, A N Phillips, et al.
Antiviral Therapy|May 15, 2002
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA studyA Mocroft, A N Phillips, N Friis-Møller, et al.
Archives of Internal Medicine|April 24, 1995
Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with acquired immunodeficiency syndrome. Multicentre Study Group on AIDS in EuropeJ D Lundgren, S E Barton, C Katlama, et al.
Proteins|March 28, 2009
Structures of two Arabidopsis thaliana major latex proteins represent novel helix-grip foldsBetsy L Lytle, Jikui Song, Norberto B de la Cruz, et al.
Antiviral Therapy|May 14, 2003
Changes in viral load in people with virological failure who remain on the same HAART regimenAlessandro Cozzi-Lepri, Andrew N Phillips, Veronica Miller, et al.
Neurocase|September 22, 2007
Effect of propranolol on naming in chronic Broca's aphasia with anomiaDavid Q Beversdorf, Umesh K Sharma, Nicole N Phillips, et al.
Pageof 114